The connecticut prescription monitoring program (PMP) aims to support the statewide effort to detect and prevent the diversion and misuse of controlled substances and ultimately reduce accidental…

The connecticut prescription monitoring program (PMP) aims to support the statewide effort to detect and prevent the diversion and misuse of controlled substances and ultimately reduce accidental overdose deaths and promote responsible prescribing practices. The states overdose death rates, which are 68% higher than the national average, highlight the urgency of addressing this issue. Connecticuts strategic plan indicates that two main areas of focus include a robust data infrastructure and prevention efforts across the lifespan. Both areas are included in this proposal. The prescription monitoring program (PMP) is a program within the drug control division of the department of consumer protection (DCP) and proposes to achieve these goals through the following project activities: 1) modernizing and enhancing educational and training tools for users of the connecticut prescription monitoring reporting system (cpmrs) by implementing a learning management system 2) enhancing and improving data quality and reporting through error reports and data exchanges 3) expanding and maintaining interstate data sharing with continued integration of rxcheck hub and pmpi; 4) increasing compliance for non-registered cpmrs users by reviewing information on cases, meetings, and lack of training on requirements these efforts will improve the detection and prevention of the diversion and misuse of pharmaceutically controlled substances such as opioids and other prescription drugs. Expected project outcomes include: 1) increased registrations in cpmrs, and improved compliance and satisfaction of system users; 2) the ability to assess, analyze and track education training effectiveness for prescribers and dispensers within connecticut; 3) increased number of interstate connections with rxcheck hub and pmpi to improve interstate data availability for prescribers and dispensers within and outside of connecticut; 4) improved provider insight into patient prescription history to better inform clinical decisions; 5) increased prescriber satisfaction from quarterly prescribing report; 6) improved prescriber awareness related to accidental overdoses by providing death notification alerts to the decedents prescribers within the cpmrs; 7) providing data to distributors of controlled substances to help identify suspicious orders and prescribing; and, 8) increased investigations of non-compliant prescribers in connecticut. Intended beneficiaries of this project include healthcare providers, prescribers, distributors and law enforcement within and outside of connecticut. They will benefit directly from enhanced data sharing and educational opportunities. Patients will benefit from prescribers that are better informed of their prescription history, and their own prescribing habits. Connecticut residents will ultimately see decreases in non-fatal and fatal overdoses statewide as a result of these efforts.